Wells Fargo
BHVN icon

Wells Fargo’s Biohaven BHVN Stock Holding History

Wells Fargo’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,800
Closed -$548K – 6918
2024
Q2 		$548K Buy
+15,800
New +$625K ﹤0.01% 3850

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's BHVN Position: Q1 2026 in Review

Wells Fargo reduced its Biohaven (BHVN) stake by 39% in Q1 2026, selling an estimated $640K and leaving 93,041 shares worth $787K. The position accounts for ﹤0.01% of the portfolio, ranked #3878.

Wells Fargo first reported a position in BHVN in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.47M in Q1 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Wells Fargo held 93,041 shares of Biohaven worth $787K as of Q1 2026.
  • Wells Fargo sold 58,475 Biohaven shares in Q1 2026, an estimated $640K.
  • Biohaven made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3878 holding.
  • Wells Fargo first reported a position in Biohaven in Q4 2022 and has held it in 14 quarters since.
  • Wells Fargo's Biohaven position peaked at $2.47M in Q1 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.